Kp. Briski, CENTRAL OPIOID RECEPTORS MEDIATE GLUCOPRIVIC INHIBITION OF PITUITARY LH-SECRETION, American journal of physiology: endocrinology and metabolism, 35(4), 1997, pp. 517-522
The present studies investigated the significance of glucoprivic metab
olic signals, particularly those of central origin, to the regulation
of pituitary luteinizing hormone (LH). Groups of gonadectomized (GDX)
adult male rats were treated with 2-deoxy-D-glucose (2-DG), an inhibit
or of glycolysis, by either intravenous (50, 100, or 200 mg/kg) or int
racerebroventricular (5, 20, or 100 mu g/rat) administration. Systemic
drug treatment caused a significant decrease in mean plasma LH levels
compared with saline-treated controls. Intracerebroventricular admini
stration of 2-DG was also efficacious in suppressing circulating LH; a
nimals treated with either of the two highest doses of the drug exhibi
ted a significant reduction in plasma LH. In vitro studies examined di
rect effects of 2-DG on pituitary gonadotrope secretory activity. Expo
sure of anterior pituitary tissue to 2-DG during short-term perfusion
had no significant impact upon either basal or gonadotropin-releasing
hormone-stimulated LH release. Finally, groups of GDX rats were pretre
ated by intracerebroventricular administration of either the nonselect
ive opioid receptor antagonist, naltrexone, or the selective mu-opioid
receptor antagonist, beta-funaltrexamine (beta-FNA), before intraveno
us injection of 2-DG. Both receptor antagonists were observed to atten
uate the suppressive effects of 2-DG: on circulating LH in these anima
ls. In summary, treatment of GDX rats with the glucose antimetabolite,
2-DG, decreased plasma LH, suggesting that metabolic signaling of cel
lular glucose oxidation is of physiological importance to the regulati
on of pituitary hormone secretion. Findings that plasma LH was diminis
hed in animals treated intracerebroventricularly with 2-DG implicate c
entral glucoprivic receptors in neuroendocrine mechanisms governing th
e reproductive endocrine axis. Attenuation of 2-DG-induced decreases i
n circulating LH by opioid receptor antagonists suggests that these re
ceptors, particularly the mu-subtype, mediate central effects of gluco
privation on circulating LH.